PK MED Strengthens Its Strategic and Scientific Governance to Support the Development of Its Therapeutic Micro-implants

PK MED, a French biotechnology company founded by Truffle Capital (founder of Abivax and Carvolix), developing therapeutic micro-implants to address major medical needs, today announces a significant strengthening of its governance. The company is strengthening the structure of its Board of Directors and Scientific Advisory Board to support the upcoming Phase 2 entry of its most advanced drug candidate, ARTHRELIS (treatment of gout flares), and to accelerate...
Anglais

ELFA Vape Aerosols Less Harmful Than Cigarette Smoke: Study

Levels of 17 constituents in aerosols from ELFA, a pod system vape by ELFBAR, are undetected or substantially lower than those in cigarette smoke, reveals the...
Anglais

New UFS 5.0 Embedded Flash Memory Devices from Kioxia Enable On-Device AI

Kioxia Corporation, a world leader in memory solutions, today announced its UFS(1)5.0 embedded flash memory solutions, designed to deliver the performance, efficiency and capacity required for the next generation of AI-enabled mobile and edge devices. The new solutions will be demonstrated next week atFMS: the Future of Memory and Storageand are now available as commercial samples in 1 TB and 512...
Anglais

Kioxia Announces Next-Generation E1.S SSDs for AI and Hyperscale Environments

Kioxia Corporationtoday announced the KIOXIA NX1 Series of solid-state drives (SSDs), a new generation of E1.S PCIe®5.0 NVMe™ data center SSDs, and Kioxia’s first SSD with direct liquid cooling support. The KIOXIA NX1 Series features Kioxia’s next-generation, in-house developed controller architecture enabling unique capabilities today while providing a foundation for future features. The new drives are engineered to...
Anglais